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Abstract
Introduction: Public health programmes recommend timely medical treatment for Buruli ulcer (BU) infection to
prevent pre-ulcer conditions from progressing to ulcers, to minimise surgery, disabilities and the socio-economic
impact of BU. Clarifying the role of socio-cultural determinants of timely medical treatment may assist in guiding
public health programmes to improve treatment outcomes. This study clarified the role of socio-cultural
determinants and health system factors affecting timely medical treatment for BU in an endemic area in Ghana.
Methods: A semi-structured explanatory model interview based on the explanatory model interview catalogue
(EMIC) was administered to 178 BU-affected persons. Based on research evidence, respondents were classified as
timely treatment (use of medical treatment 3 months from awareness of disease) and delayed treatment (medical
treatment 3 months after onset of disease and failure to use medical treatment). The outcome variable, timely
treatment was analysed with cultural epidemiological variables for categories of distress, perceived causes of BU,
outside-help and reasons for medical treatment in logistic regression models. The median time for the onset of
symptoms to treatment was computed in days. Qualitative phenomenological analysis of respondents’ narratives
clarified the meaning, context and dynamic features of the relationship of explanatory variables with timely medical
treatment.
Results: The median time for initiating treatment was 25 days for pre-ulcers, and 204 days for ulcers. Income loss
and use of herbalists showed significantly negative associations with timely treatment. Respondents’ use of
herbalists was often motivated by the desire for quick recovery in order to continue with work and because
herbalists were relatives and easily accessible. However, drinking unclean water was significantly associated with
timely treatment and access to health services encouraged timely treatment (OR 8.5, p = 0.012). Findings show that
health system factors of access are responsible for non-compliance to treatment regimes.
Conclusions: Findings highlight the importance of an integrated approach to BU control and management
considering the social and economic features that influence delayed treatment and factors that encourage timely
medical treatment. This approach should consider periodic screening for early case-detection, collaboration with
private practitioners and traditional healers, use of mobile services to improve access, adherence and treatment
outcomes.
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Introduction
Public health programmes recommend early medical
treatment for Buruli ulcer (BU) infection to prevent pre-
ulcer conditions from progressing to ulcers, minimise
osteomyelytis (infectious inflammation of the bone or
marrow), need for surgical intervention, disability and
improve treatment outcomes [1,2]. However, affected
persons may delay medical treatment due to various so-
cial, economic, cultural and health system factors [3-6].
Clarifying the role of socio-cultural determinants of
timely and delayed medical treatment for BU may assist
in the design of public health programmes that are
socio-culturally sensitive to improve disease outcomes,
lessen the disease burden, and treatment costs to health
facilities.
Buruli ulcer, caused by the environmental pathogen, M.
ulcerans, is a debilitating disease of the skin and sometimes
the bone tissues [5-8]. The pre-ulcer stage of infection is
characterised by nodules, plaques and oedemas [8,9]. The
time from progression of a pre-ulcer to an ulcer varies,
ranging from a few weeks to several months [7].
Until recently, wide surgical excisions that require
lengthy hospital stays for recovery were the only treatment
[6,10-13]. However, studies show that surgery alone can-
not completely remove all necrotic tissues, and the possi-
bility of recurrence is high [14-16]. Using antibiotics
recommended by WHO – rifampin and streptomycin -for
nodules and early lesions is effective in reducing lesions
thus minimising the extent of surgical excision and disease
sequalae [2,13,17-19].
Even though there is no standard definition for accept-
able treatment delay, public health programmes encourage
BU-affected persons to seek treatment as early as possible,
during the pre-ulcer stage of infection, which is often
characterised by a nodule, plaque, or oedema. When treat-
ment is delayed and lesions progress into ulcers, they
typically require a long time to heal, and scarring, contrac-
tures and disabilities result [6,9,11,12,20].
Studies in Benin and Ghana have investigated the obsta-
cles to medical treatment which include, fear of recurring
infections after surgical treatment, anxiety about the out-
come of surgery, fear and concern about scarring and dis-
abilities after treatment, late detection of BU-related skin
trauma or lesions, perceived seriousness of infection and
local beliefs of spiritual causes that require the use of
traditional healers, particularly herbalists [1,4,10,19,21].
Additional obstacles to seeking medical treatment are high
transport costs of seeking treatment, costs of food during
hospitalisation and the social and economic implications
of providing care to affected relatives during hospital
admissions. [3,4,7,10,12,19,21].
It is expected that awareness and knowledge of antici-
pated debilitating disease outcomes of BU may prompt
timely and appropriate medical treatment. However,
this is not the case in many BU-endemic countries
[4,12,19,21,22]. Therefore, clarifying the role of socio-
cultural barriers to timely treatment for BU is likely to
strengthen case-detection, improve access to treatment
and outcomes, and consequently lessen disease morbidity
and financial costs of surgery to health facilities. Further-
more, socio-cultural studies for BU are a priority of the
WHO research agenda [2]. Nevertheless, there are too
few of such studies and many were conducted before
the introduction of the WHO-recommended antibiotic
therapy. This paper examined socio-cultural determi-
nants of timely medical treatment for pre-ulcers and
delayed medical treatment for ulcers in an endemic area
in Ghana.
Methods
Study area
The study was undertaken in the Ga-West and Ga-South
Municipalities of the Greater Accra region from November
2008 to July 2009. The Ga-West Municipality (GWM) is
predominantly rural, with a population of 215,824, based
on projected population estimates from the national hous-
ing and population census (Ga-West Municipal Health Dir-
ectorate, annual report, unpublished). Both municipalities
cover a land area of 692 square kilometres. Seventy-six
percent of the land area of the Ga-South Municipality
(GSM) is predominantly urban and peri-urban while
24% is rural [23]. Health services are inaccessible to the
majority of the population due to distance, terrain, poor
road infrastructure and inadequate transport (Figure 1).
The GWM has 1 government hospital, 5 community
clinics, 9 private hospitals and clinics, and 7 private ma-
ternity homes. The major BU medical treatment centres
are the Amasaman hospital (AH), which is the main
referral centre for BU treatment in the Greater Accra
region and the Kojo Ashong clinic. The Obom health
centre provides medical treatment for BU patients in the
GSM and the AH is one of the main referral centres for
BU treatment in the Greater Accra region. BU ranks third
on the list of top ten diseases reported at the out-patient
departments in the government health facilities in both
municipalities.
The study sample and sampling strategy
To identify as many BU affected persons as possible, a sam-
ple of 181 respondents was obtained from 67 communities
and 3 BU treatment centres – The Amasaman hospital
(AH), the Kojo Ashong clinic (KAC) and the Obom health
centre (OHC). These health facilities provide antibiotic
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treatment (rifampicin and streptomycin) and surgery. The
AH admits approximately 90 persons with BU infection
each year. Based on these estimates, we enlisted all BU
patients receiving treatment at the AH, KAC and OHC
and all affected persons from 67 endemic communities.
Parents acted as proxy respondents for children below
5 years of age. However, since help-seeking choices are
largely determined by parents and guardians, children older
than 5 years were interviewed first and subsequently par-
ents and guardians; responses reflected consensus opinion.
The explanatory model interview catalogue (EMIC)
A semi-structured explanatory model interview based on
the EMIC framework for cultural epidemiology [24] was
developed for this study. Prior ethnographic research
and earlier studies [3] informed the design and the
Figure 1 Map of the study area – the Ga-West and Ga-South Municipalities showing health facilities and study communities.
*Inset is a map of Ghana showing the location of the study municipalities. To avoid overcrowding on the map, only some communities are shown.
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formulation of questions for the EMIC. The instruments
were developed in English, but interviews were con-
ducted in the local Ghanaian languages (Ga, Ewe and
Twi) spoken by respondents in the study areas.
The EMIC examined use of timely medical treatment,
patterns of distress (PD) and perceived causes (PC). Pat-
terns of distress refer to illness-related problems and
concerns and local experiences of BU illness. Perceived
causes denote local ideas of causes for BU. Children
were not asked PD questions that were irrelevant to
their socio-cultural context. Such questions referred to
marriage, income and employment. Respondents were
asked to indicate the provider-type for pre-ulcers and
ulcers. Those respondents who stated that they used
medical treatment from recognised municipal and pri-
vate health facilities were asked to indicate reasons for
medical treatment and also asked to state the time lapse
between onset of symptoms and medical treatment. Nar-
ratives in response to open-ended questions elaborated
and explained coded categories and their responses.
Data management and analysis
Categorical and numeric data from the EMIC interviews
were double entered using EPI Info (Centers for Disease
Control and Prevention, Atlanta, GA, USA, version 3.4.1),
and subsequently cleaned and analysed using STATA 10.1
data analysis and statistical software (StataCorp, Lakeway
Drive, College Station, Texas). Median time lag from onset
of symptoms and medical treatment were recorded in the
manner in which they were reported, in days, weeks, months
or years and were later converted to days for analysis.
Unlike malaria and tuberculosis, there is no standard def-
inition distinguishing delay from timely treatment for BU.
The pre-ulcer phase of BU infection could vary from a few
weeks to several months [25]; one study has indicated an
average time of 1–3 months [9]. Host immune inflamma-
tory response plays an important role in the progression of
pre-ulcers to ulcers and therefore this was taken into con-
sideration in the operational definition for timely treatment
[26]. Timely treatment was therefore defined as seeking
medical treatment for pre-ulcers and ulcers within 3 months
after the onset of infection. Those respondents who
initiated medical treatment 3 months after infection and
those with pre-ulcers and ulcers who did not seek medical
treatment were classified as delayed treatment seeking. Ini-
tially 181 respondents were interviewed but three (3)
respondents who had pre-ulcers (with illness duration from
10 days to 3 weeks), were not included in the analysis
because their treatment status was inconclusive. It was pre-
sumed they might seek timely or delayed treatment later.
A binary outcome variable (timely treatment) was cre-
ated. To determine how features of illness explanatory
models affected timely treatment, unadjusted (univariate)
analysis first considered demographic, PD, PC, Help-
seeking (HS) and reasons for treatment variables at
p < 0.25 [27] for the outcome variable. The only exception
was ‘disrupted education’ (p = 0.628) because respondents’
narratives commonly suggested the influence of this vari-
able on treatment. Adjusted (multiple regression) models
considered variables from the unadjusted analysis with
p-values <0.25. Odds ratios with their respective 95% confi-
dence intervals were calculated for variables in the model.
Narrative data were translated and transcribed in English
during the interview by the data collector, entered into MS
Office Word 2007 (Microsoft Corporation) and imported
into MAXQDA, software for textual analysis (verbi Software
Consult Sozialforschung, GmbH, Marburg, Germany). Ill-
ness narratives and quantitative variables of interest for PD,
PC, HS and reasons for medical treatment were imported
into MAXQDA to select respondents with a desired profile
of responses for phenomenological qualitative analysis. This
approach allowed clarification of the relationship of explana-
tory variables to timely and delayed medical treatment. The
regression analysis explained which variables were related to
timely or delayed medical treatment and the narratives were
analysed to explain the nature of such effects.
Ethical considerations
Verbal informed consent was obtained from all adult
respondents and parental caretakers or guardians of chil-
dren. The study was approved by the ethical review
committee of the Ministry of Health, Ghana, and the
ethics commission of Basel (Ethikkommission beider
Basel, EKBB) in Switzerland.
Results
Demographic characteristics of the study respondents
Based on our operational definition of timely treatment
(see methods section), 48 (27.0%) respondents initiated
timely treatment and 130 (73%) respondents delayed treat-
ment for their illness conditions. Among the 130 respon-
dents who delayed treatment, 39 did not seek treatment
for their illness conditions.
A total of 166 respondents had ulcers during the
study: 37 (22.3%) initiated timely medical treatment, 91
(54.8%) delayed treatment and 38 (22.9%) did not seek
treatment. Fifteen (15) respondents had pre-ulcers dur-
ing the study: 11 (73.3%) used timely treatment, 1 (6.7%)
delayed treatment, and 3 (20%) respondents were not
included in the analysis because their treatment status
was undetermined (see methods).
Most of the respondents had completed primary school
(58.3% timely treatment and 51.5% delayed treatment).
Respondents who were employed were mainly unskilled
workers. Only 22.2% of respondents who sought timely
treatment and 17.9% of respondents who delayed treat-
ment mentioned that their income was regular (table 1).
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Illness experiences and treatment delay
The median time for initiating timely treatment was
30 days and 204 days for delayed medical treatment.
Table 2 shows the univariate analysis of variables for
demographic characteristics and table 3 shows univariate
analysis for categories of illness experience (PD), illness
meaning (PC), outside-help and reasons for medical treat-
ment variables. Table 4 presents results for the adjusted
(multivariate) logistic model for variables selected from
the univariate analysis at p < 0.25.
None of the demographic variables showed any signifi-
cant association with timely treatment (table 2). However,
functional disability and income loss as illness experiences
were negatively associated with timely treatment only in
the univariate analysis (table 3).
In their narratives, respondents linked income loss with
the inability to continue working while seeking treatment.
Respondents who delayed medical treatment also explained
how their desire to continue with work overshadowed the
need to use medical treatment. Many used herbalists and
purchased analgesics, blood tonics and antibiotics from
local chemists. They mentioned that the key reason for
considering medical treatment, after herbal treatment had
failed, was to get better to continue working. Most parents
and guardians were unskilled workers and earned meagre
wages. They expressed a genuine difficulty in stopping work
to take their children and wards for medical treatment.
However, respondents with pre-ulcers who initiated timely
treatment continued working since they did not experience
pain or much discomfort.
Perceived causes and treatment delay
From the univariate analysis, PC variables did not show any
significant relationship with timely treatment. However
after adjusting for confounding factors (such as education,
PD variables, help providers aside from herbalists, reasons
Table 1 Demographic characteristics of respondents*
Demographic characteristics Timely Treatment N=48 Delayed Treatment N=130 P-values
N=178
(%) (%)
Treatment status
Sex 0.398
Males 41.7 50.0
Females 58.3 50.0
Age 0.571
Less than 15-years-of age 56.3 44.6
15-30 years 25.0 31.5
30-45 years 6.3 10.8
≥ 45 years 12.5 13.1
Education 0.216
No education 14.6 26.9
Primary 58.3 51.5
Secondary and above 27.1 21.5
Occupation 0.279
Pupil/student 64.6 52.3
Unskilled labour 20.8 26.9
Skilled labourer 2.1 9.2
Unemployed 12.5 11.5
Income 0.367
Regular and dependable 18.5 16.2
Uncertain/ Cannot tell 42.7 43.1
Irregular 38.8 40.8
Marital status 0.962
Never married 70.8 67.7
Married 22.9 23.8
Separated, divorced and widowed 6.3 8.5
*Results are stated in percentages. Fisher’s exact test was used for comparison between ‘timely treatment’ and ‘delayed treatment’. Timely treatment is defined as
seeking treatment < 3 months from first awareness of symptoms to appropriate help-seeking.
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for medical treatment besides easy access to treatment),
drinking unclean water as a PC, was significantly associated
with timely treatment (OR 3.8, p=0.011) in the multivariate
analysis (table 4). Respondents who linked their illness to
drinking unclean water attributed this knowledge to messages
from health staff. They bemoaned the absence of potable
water in their communities and explained that they often
fetched water from rivers, ponds and unprotected dams,
(which animals also drank from), for domestic use. Some-
times rivers were used as thoroughfare to work and school.
The following narrative explains the use of unclean water
from a stream for drinking and as an access route to school:
I believe it is due to wading, fishing and drinking
water from the Doblo stream which I drink often. I
also go fishing in the stream. Sometimes I have to
wade through the same stream on my way to school
and the farm.
(15-year-old male respondent)
Help-seeking behaviour
Prior use of a traditional healer (herbalist and spiritual-
ist) showed a negative association with timely treat-
ment in the unadjusted model (table 3). Furthermore,
the use of herbalists showed significantly negative asso-
ciations with timely treatment after adjusting for con-
founding (OR, 0.2, p = 0.002), (table 4). Respondents’ use
of herbalists was often motivated by the desire for quick
recovery in order to continue with work. Narratives sug-
gested that herbalists were relatives (Fathers, Uncles or
Grandfathers), itinerant, and they lived nearby, thus mak-
ing them easily accessible (Figure 2). During interviews,
there were occasional encounters with herbalists. They ei-
ther came to review the BU-illness status of relatives or
clients, or they were carrying out their itinerant business.
Respondents had initial confidence in the claims of
herbalists about their ability to treat BU. They often
explained that herbalists were good at exposing the
cotton wool, (translation from local name for infected
Table 2 Unadjusted (univariate) analysis of background variables associated with timely and delayed treatment
Socio-demographic variables Timely treatment N=178 P-values
OR (95% CI)
Sex
Males Ref
Females 1.4 (0.72, 2.73) 0.324
Age
Less than 15-years-of age Ref
15-30 years 0.6 (0.29, 1.38) 0.249
30-45 years 0.5 (0.12, 1.74) 0.252
≥ 45 years 0.8 (0.27, 2.14) 0.601
Education
Primary Ref
Secondary and above 1.1 (0.50, 2.45) 0.795
No education 0.5 (0.19, 1.21) 0.118
Occupation
Pupil/student Ref
Unskilled labour 0.6 (0.28, 1.42) 0.265
Skilled labourer/Professional 0.2 (0.02, 1.47) 0.110
Unemployed 0.4 (0.08, 1.73) 0.205
Other (too young to be either employed or in school) 2.9 (0.62, 13.86) 0.176
Income
Irregular Ref
Uncertain/ Cannot tell 1.2 (0.55, 2.52) 0.663
Irregular 1.9 (0.78, 4.67) 0.166
Marital status
Never married Ref
Married 0.9 (0.42, 2.03) 0.833
Separated / divorced and widowed 0.7 (0.19, 2.69) 0.610
*Odds ratios, confidence intervals and p-values for all variables included in the adjusted model are shown in the table. OR = odds ratios, CI = confidence intervals
Timely treatment is defined as seeking treatment < 3 months from first awareness of symptoms to appropriate help-seeking.
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tissues) but were not very effective in treating the sores.
Respondents, who delayed treatment for ulcers, indi-
cated that herbal treatment was often used in combin-
ation with analgesics, antibiotics and balms obtained
from drug peddlers or used alone.
Respondents resorted to medical treatment, when
herbal treatment seemed ineffective and wounds were
not healing fast enough. The following narrative explains
how the dynamics of easy access to herbal treatment
and assurances from the herbalist, coupled with the de-
sire to resume work, influenced the respondent’s choice
for herbal treatment which subsequently delayed medical
treatment. This respondent lives 8 kilometres away from
the nearest health centre.
I applied herbs to the boil at home and later invited a
herbalist to treat me at home, because my treatment
was not working. The herbalist assured me that his
treatment was effective. His treatment only removed
the ‘cotton wool’, (translation from the local name for
infected tissues) but left a very big sore. After herbal
treatment a private practitioner was injecting me and
giving me pills daily at home. I always felt dizzy after
the injections. I wanted to be treated at home to
recover quickly to go back to work. I have spent so
much money treating this disease and I have not been
able to work for 9 months since I had this condition. I
am a hairdresser and I have lost all my customers.
(35-year-old female respondent)
Access to health facilities, knowledge of antibiotic
treatment influence of family and friends and medical
treatment
Self-referral, referral by family and friends, the desire for
quick recovery and knowledge of the effectiveness of
antibiotic treatment showed significant associations with
Table 3 Unadjusted (univariate) analysis of socio-cultural variables associated with timely and delayed treatment*
Explanatory variables Timely treatment N=178 P-values
OR (95% CI)
Patterns of distress
Pain 0.5 ( 0.21, 1.20) 0.118
Functional disability 0.4 (0.20, 0.91) 0.029
Disrupted education 0.8 (0.44, 1.65) 0.628
Loss of income 0.4 (0.20, 0.92) 0.030
Anxiety 0.6 (0.33, 1.27) 0.204
Embarrassed about condition 0.6 (0.29, 1.11) 0.098
Recurring infection 3.0 (0.90, 9.65) 0.073
Perceived causes
Drinking unclean water 1.6 (0.83, 3.21) 0.158
Prone to illness 0.5 (0.16, 1.54) 0.229
Weakness of blood 0.6 (0.30, 1.26) 0.186
Outside-help
Herbalist 0.3 (0.15, 0.60) 0.001
Fetish/spiritualist 0.2 (0.07, 0.84) 0.025
Prayer camp 0.4 (0.16, 1.08) 0.071
Municipal health centres 2.7 (1.24, 5.88) 0.012
Government hospital outside the district 0.6 (0.22, 1.49) 0.252
Nothing 0.3 (0.06, 1.13) 0.073
Reasons for medical treatment
Easy access to health centre 8.3 (2.46, 27.94) 0.001
Self-referral 2.3 (1.13, 4.57) 0.022
Referral by family and friends 2.9 (1.39, 6.09) 0.005
Get well quickly 3.7 (1.52, 8.79) 0.004
Effectiveness of antibiotic treatment 3.1 (1.38, 6.88) 0.006
*Only variables with p-value <0.25 are shown in the table except disrupted education as a pattern of distress, because it was often mentioned in respondents’
narratives with reference to medical treatment. OR = odds ratios, CI = confidence intervals and p-values for all variables included in the adjusted model are shown
in the table. Values in bold indicate statistical significance (p≤ 0.05). Timely treatment is defined as seeking treatment < 3 months from first awareness of
symptoms to appropriate help-seeking.
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timely medical treatment in the univariate analysis
(table 2). However, after adjusting for confounding only
easy access to health facilities showed a significant asso-
ciation with timely medical treatment (OR 8.5, p = 0.012),
(table 4). Respondents who accessed health centres with
very little difficulty lived nearby and commuted easily for
treatment. Respondents attributed their knowledge of the
availability and effectiveness of antibiotic treatment at
medical facilities to community health education pro-
grammes. They also conferred with family and friends for
advice on treatment choices. In some cases, family and
friends advised the use of medical treatment; others
advised otherwise. The following narrative shows how
advice from family could influence behaviour and
possibly lead to delayed treatment, with implications for
emotional, physical and financial distress.
This condition has caused me a lot of inconvenience. It
(sore) smells so bad and I have lost the desire for food.
I cannot sit on my bottom (locus of the sore) for
months. I cannot explain my situation; I am in a total
mess. I don’t work anymore so I don’t have any
income. I have left the family behind at home and I
am in the hospital. Men cannot take care of children
properly so I worry about the situation in the house. I
was advised by so many people – family and friends.
Any time someone advises me to try something I do it.
I tried all kinds of herbs, pills and balms. I also went
Table 4 Adjusted (Multivariate) analysis of background variables and socio-cultural variables associated with timely
and delayed treatment *
Treatment status Timely treatment N=178 P-values
OR (95% CI)
Education
Primary Ref
Secondary and above 0.5 (0.16, 1.62) 0.254
No education 0.4 (0.09, 1.58) 0.180
Patterns of distress
Problems with mobility and use of affected limbs 0.8 (0.29, 2.50) 0.762
Disrupted education 0.4 (0.12, 1.63) 0.220
Loss of income 0.5 (0.13, 1.75) 0.267
Anxiety 0.6 (0.25, 1.57) 0.316
Embarrassed about condition 0.6 (0.22, 1.41) 0.216
Recurring infection 3.5 (0.71, 17.63) 0.125
Perceived causes
Drinking unclean water 3.8 (1.34, 10.63) 0.011
Prone to illness 0.2 (0.05, 1.09) 0.064
Weakness of blood 0.6 (0.24, 1.79) 0.406
Outside-help
Herbalist 0.2 (0.08, 0.56) 0.002
Fetish/spiritualist 0.2 (0.05, 1.09) 0.064
Prayer camp 0.4 (0.13, 1.32) 0.136
Municipal health facilities 1.2 (0.31, 4.68) 0.792
Government hospital outside the district 0.3 (0.05, 1.56) 0.150
Nothing 0.4 (0.04, 2.96) 0.343
Reasons for medical treatment
Easy access to health centre 8.5 (1.61, 44.47) 0.012
Self-referral 2.3 (0.74, 6.98) 0.151
Referral by family and friends 1.6 (0.57, 4.43) 0.374
Get well quickly 1.5 (0.30, 7.32) 0.620
Effectiveness of antibiotic treatment 2.8 (0.55, 14.51) 0.215
*Odds ratios, confidence intervals and p-values for all variables included in the adjusted model are shown in the table. Values in bold indicate statistical
significance (p≤ 0.05). The fitness of the model was assessed with the p-value (p < 0.001). OR = odds ratios, CI = confidence intervals. Timely treatment is defined as
seeking treatment < 3 months from first awareness of symptoms to appropriate help-seeking.
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for prayers. My Pastor said I should go to the hospital
so that my condition does not become worse.
(32-year-old female respondent)
Challenges associated with treatment adherence
Aside from the desire to continue with work, narrative
accounts of respondents identified the influence of other
socio-economic factors responsible for treatment delay.
These included the cost of food if admitted to the hos-
pital and transport expenses to medical facilities. Many
of these respondents, who delayed medical treatment,
described these costs as enormous, which their meagre
incomes from small-scale farming, other farm work,
odd-jobs and petty trading could not support. They sta-
ted that they had to leave behind some money for the
family upkeep when admitted for surgery at the hospital.
Of the 91 respondents who delayed medical treatment
for ulcers, nine (9.9%) could not adhere to treatment.
Reasons given were distance to the health centre, high
costs of transport, difficulty in obtaining transport, dis-
satisfaction with slow-healing of antibiotics, lack of
money for food while on admission, advice of family to
discontinue treatment and the perceived ineffectiveness
of medical treatment influenced by the idea that BU is
caused by witchcraft.
Nine (9) of the 48 respondents (18.5%) who initiated
timely medical treatment for their pre-ulcer conditions failed
to adhere to treatment regimes. Some of them discontinued
treatment and resorted to self medication with antibiotic
capsules, particularly Terramycin and Phenoxymethylpeni-
cillin (commonly known as penicillin v), which were pur-
chased from chemist shops or itinerant drug peddlers.
Explanations were based on difficulty obtaining transport to
health centres, long distance to health centres from place of
residence, travel time interfering with work schedules and
lack of money for transport. The following account of a re-
spondent, an itinerant petty trader, who lives 18 kilometres
from the nearest health centre, is characteristic:
I wanted to get well quickly as the health people have
been telling us. One day when I was selling, I met
some people from the hospital giving a talk about
Buruli ulcer. When I showed them my boil they said it
was Buruli ulcer and they asked me to go to the Kojo
Ashong clinic for treatment. Everyday, I had to walk
for a long time to get to the Kojo Ashong clinic. I was
given injections and pills. I did not have enough time
to take care of the family before leaving home. The
clinic is far away from my house and so it was very
difficult to go each time. I come back from the clinic
very tired, and then I have to go and sell.
(28 year-old female respondent)
Discussion
The aim of this study was to clarify the influence of
socio-cultural factors on timely treatment for BU infec-
tion. Because of the absence of a standard definition for
measuring timely treatment for BU, we formulated a
working definition of timely treatment as medical treat-
ment within 3 months of awareness of infection. This
definition was based on studies that estimated an average
time of 1–3 months for the pre-ulcer phase of BU [1,25].
Our findings suggest that timely treatment for BU is
greatly influenced by health system factors, poverty and
the socio-cultural environment of affected persons. Access
to health services, referral by family and friends and
awareness of the effectiveness of medical care encouraged
timely treatment. Furthermore, our findings confirm earl-
ier studies that explained delayed medical treatment for
BU as a result of social and economic factors, such as the
absence of reliable transport to health facilities, high costs
of transport to medical facilities, prolonged stay in the
hospital and loss of income, and disrupted education
[3-5,10,12,21,22,28].
Previous studies have established an association be-
tween witchcraft as a PC and delayed medical treatment
after prior use of traditional healers, particularly diviners.
[4,21,22]. However, our findings did not show any indi-
cation of such an association between local ideas of
witchcraft delaying timely treatment. Nonetheless, the
use of spiritualists and herbalists for treatment had a
negative association with timely treatment. Spiritualists
and herbalists were frequently used however because
they were easily accessible and provided home-based
care which minimised absenteeism from home for med-
ical treatment.
Figure 2 Herbal treatment for ulcers*.
*Respondent has had BU for more than 3 years and is being treated
at home by his grandfather, a herbalist. Respondent’s current
condition is from recurring BU infections. The green patches
(arrowed) are herbal dressings. Note the multiple scarring. Picture
taken by Mercy Ackumey in the Otuapleam community, 2008.
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Study limitations, strengths and implications for control
Recall bias may have been an issue since study data were
mainly based on respondents’ accounts. Because many
respondents had to report both on providers visited and
time when they initiated treatment retrospectively, recall
bias is a potential problem. Probes were used however,
to minimise recall bias and under-reporting. We inter-
viewed fewer respondents with pre-ulcers (15) compared
with those who had ulcers (166). The skewed nature of
our data can be explained by local practices of incising
nodules and applying herbs to pre-ulcer lesions which
accelerates the progression of pre-ulcer lesions to ulcers.
A recent study in a BU-endemic area in Ghana also
showed fewer pre-ulcer cases (23.3%) than ulcer cases
(76.7) during an initial health-screening exercise. How-
ever, the situation reversed after one year of intensive
health education[29]. The impact of this practice has
been reported in another paper [30].
Narratives explaining the influence of cultural epidemio-
logical explanatory variables clarified the socio-cultural con-
text of timely treatment and enhanced the social contextual
analysis of logistic regression models. Findings provide
insight into features of both timely and delayed treatment
for BU and indicate programme-relevant issues for control.
These include improving access to medical treatment and
fostering provider-patient interactions through mobile ser-
vices, involving private health care practitioners to improve
access and strengthening support networks to raise aware-
ness and provide emotional support. These points are dis-
cussed in greater detail in the discussion that follows.
Improved access to services for timely treatment and
adherence
A study in Benin reported a shorter median time delay of
120 days for ulcers compared with 204 days in our study
[7]. The median time for delayed treatment and the long
duration of infection for ulcers is a matter of concern be-
cause this might lead to prolonged treatment with higher
costs and disability that deepens poverty [3,5,7,28]. Based
on the median time for initiating timely treatment in our
study, which was 30 days and the average time for incuba-
tion for M. ulcerans (between 1–3 months) [9], we suggest
that persons infected with M. ulcerans infection, should
seek medical treatment within a month after awareness of
symptoms. It must be noted however that improved access
to treatment is required to encourage affected persons to
seek treatment within a month of infection,
In Benin, median time delay for BU decreased from
120 days to 30 days after the implementation of a programme
to improve access to care [7]. Study findings indicated that
although proximity of health facilities to residences encour-
aged timely care, distance, travel time to health facilities
that disrupted work schedules, lack of money for transport,
unavailability of transport and loss of wages when seeking
care accounted for non-adherence to a full course of anti-
biotic treatment. A study in Ghana revealed that low in-
come also accounted for non-adherence to tuberculosis
treatment. People defaulted when they felt a bit better in
order to work and continue taking care of the family [31].
Transport costs and distance from health facilities have
been responsible for treatment delays and adherence for tu-
berculosis [32]. Our study finding which confirms this link
between access, poverty and disrupted livelihoods, on the
one hand, and non-adherence to antimicrobials is a matter
of concern; it is likely to increase antibiotic resistance and
compromise effective treatment [33].
It is important that public health practitioners consider
the socio-economic conditions of BU-affected persons.
These conditions have implications for designing pro-
grammes and providing services to improve disease
outcomes, lessen disease burden, limit dependency on
herbalists and encourage timely treatment, and mitigate
the effects of poverty. Mobile services are likely to increase
interactions between BU patients and health workers,
which are crucial in motivating commitment to treatment,
providing emotional support and encouraging adherence
to antibiotic treatment regimes for positive treatment out-
comes, namely cure and reduced recurrences.
The use of motorcycles to improve access to health
services is not a new phenomenon in Africa. Motorcycle
ambulances have been used in Malawi to improve access
to health facilities, improve referrals and consequently
reduce maternal mortality [34]. In South Africa, off-road
motorcycles have been used for timely collection of
blood-specimens that give remote clinics access to diag-
nostic laboratory services [35]. Collaborating with pri-
vate health practitioners might also be considered as a
pragmatic and cost-effective approach to improve access
[30,36]. However, this intervention requires supervision
and monitoring by the municipal health management
team to ensure that drug protocols are followed strictly
and wounds are managed properly.
The socio-cultural context of poverty and timely
treatment
The failure to initiate timely medical treatment was asso-
ciated with concern for securing livelihoods. Most BU-
affected persons are poor, unskilled labourers, petty tra-
ders, farmers or fishermen, with irregular work schedules
and incomes [3,12,28,29,37]. Their concern about loss of
livelihoods and income is reasonable and well-founded.
Studies have shown the immense socio-economic burden
of BU on already impoverished families and households
[12,19,37]. Some families, borrow money, sell assets and
reduce farm sizes to pay for transportation and feeding
costs related to BU treatment, thus entrenching them dee-
per into poverty [28,29]. Ironically, however, treatment
delays account for longer periods of treatment, higher cost,
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longer hospitalisation, loss of livelihoods and increased
poverty [29].
Influence of use of herbalists on timely treatment
Many respondents who delayed treatment for ulcers had
first used herbalists (43.1%). Herbal treatments and
herbalists are used widely for various ailments in Ghana
[38]. The use of herbalists however, is known to delay
medical treatment for BU [1,3] and tuberculosis [39].
The pre-ulcer stages of BU infection are usually without
pain and unless secondary infection is introduced, ulcers
are generally painless [20], which makes it easier to delay
treatment to continue working.
The consanguine relationship of herbalists with our
study respondents and the itinerant nature of their ser-
vices made them easily accessible. Herbalists play a crucial
role in providing services when biomedical treatment is
inaccessible, particularly in a culture where herbal medi-
cine is widely used [38]. Previous studies recommend their
integration in the health system to facilitate referrals
[3,30]. Currently, herbalists are being motivated to refer
patients to health facilities, in the study areas (personal
communication). This strategy, although laudable needs to
be explored further to consider innovative ways to enlist
their trust and cooperation.
Perceived causes and timely treatment
Respondents who initiated timely medical treatment were
more likely to attribute the cause of their illness to drinking
bad water. Even though the mode of BU transmission to
humans is unclear [40], support is weak for the assertion
that ingestion of unclean water is a possible transmission
route [41]. Local perceptions that link BU disease to drink-
ing unclean water may result from misinterpretation of
health messages that emphasise water contagion as a risk
factor for BU disease. Furthermore, the study location was
a previously guinea worm endemic area and health educa-
tion messages then emphasised drinking unclean water as a
risk factor. Therefore, there is a tendency of generalising
health messages across these two diseases. Public health
programmes must consider the disease history of commu-
nities when designing health education programmes and
present messages distinctly to avoid ambiguity. Nonethe-
less, study findings support the concern raised by earlier
studies about the need for further research on the role of
environmental factors, animals and insects in BU contagion
[25,42,43]. Such evidence would maybe help to guide and
motivate the local population to clarify the validity of pro-
blems that affect timely medical treatment.
Support networks and health education for timely
treatment
Self-referral, referral by family and friends and knowledge
of WHO-antibiotic treatment was significantly associated
with timely treatment only in the univariate analysis
(table 3). Support networks such as family and friends pro-
vide social support and offer valuable help-seeking advice.
[4,30,44,45]. The importance of community and school
health education programmes to increase awareness of
BU, and the availability and effectiveness of treatment at
medical facilities cannot be overemphasised.
Health education should also explain how initial use of
herbal treatment and self-medication delays medical treat-
ment and healing. Furthermore, health messages should
emphasise the effectiveness of WHO-recommended anti-
biotics for treating timely lesions.
Conclusions
Our findings highlight how health system factors such as
access to treatment and knowledge about the effectiveness
of medical services encouraged timely treatment, and how
poor access to treatment and socioeconomic obstacles
affected treatment adherence. The socio-cultural context
of poverty discouraged timely treatment and influenced
use of herbalists. The link between drinking water as a
perceived cause and timely treatment is a clear indication
of a positive response to health messages and shows the
impact of the control programmes even through the scien-
tific validity of this perceived cause is questionable. Never-
theless, findings highlight the importance of optimising
public health control efforts. This calls for an integrated
approach to BU management and care accounting for
social and economic barriers to timely medical treatment.
Recommended measures include, periodic screening for
timely case-detection, collaboration with private practi-
tioners to improve access to treatment and the introduc-
tion of mobile services to improve treatment outcomes
and adherence, and case-detection.
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